These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18786854)

  • 1. Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV.
    Fontaine J; Hankins C; Money D; Rachlis A; Pourreaux K; Ferenczy A; ; Coutlée F
    J Clin Virol; 2008 Nov; 43(3):307-12. PubMed ID: 18786854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women.
    Denny L; Boa R; Williamson AL; Allan B; Hardie D; Stan R; Myer L
    Obstet Gynecol; 2008 Jun; 111(6):1380-7. PubMed ID: 18515522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women.
    Rowhani-Rahbar A; Hawes SE; Sow PS; Toure P; Feng Q; Dem A; Dembele B; Critchlow CW; N'Doye I; Kiviat NB
    J Infect Dis; 2007 Sep; 196(6):887-94. PubMed ID: 17703420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
    Hawes SE; Critchlow CW; Faye Niang MA; Diouf MB; Diop A; Touré P; Aziz Kasse A; Dembele B; Salif Sow P; Coll-Seck AM; Kuypers JM; Kiviat NB
    J Infect Dis; 2003 Aug; 188(4):555-63. PubMed ID: 12898443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
    J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.
    Moscicki AB; Ellenberg JH; Farhat S; Xu J
    J Infect Dis; 2004 Jul; 190(1):37-45. PubMed ID: 15195241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women.
    Minkoff H; Feldman JG; Strickler HD; Watts DH; Bacon MC; Levine A; Palefsky JM; Burk R; Cohen MH; Anastos K
    J Infect Dis; 2004 May; 189(10):1821-8. PubMed ID: 15122518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women.
    Watts DH; Fazzari M; Minkoff H; Hillier SL; Sha B; Glesby M; Levine AM; Burk R; Palefsky JM; Moxley M; Ahdieh-Grant L; Strickler HD
    J Infect Dis; 2005 Apr; 191(7):1129-39. PubMed ID: 15747249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women.
    Gagnon S; Hankins C; Tremblay C; Forest P; Pourreaux K; Coutlée F;
    J Infect Dis; 2004 Nov; 190(9):1575-85. PubMed ID: 15478061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection.
    Mbulawa ZZ; Coetzee D; Marais DJ; Kamupira M; Zwane E; Allan B; Constant D; Moodley JR; Hoffman M; Williamson AL
    J Infect Dis; 2009 May; 199(10):1514-24. PubMed ID: 19392625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
    Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
    J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions.
    Coutlée F; Trottier H; Gagnon S; Koushik A; Richardson H; Roger M; Ferenczy AS; Franco EL
    J Clin Virol; 2009 Jun; 45(2):96-9. PubMed ID: 19398216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women.
    Viscidi RP; Snyder B; Cu-Uvin S; Hogan JW; Clayman B; Klein RS; Sobel J; Shah KV
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):283-8. PubMed ID: 15668510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-sampling is associated with increased detection of human papillomavirus DNA in the genital tract of HIV-seropositive women.
    Petignat P; Hankins C; Walmsley S; Money D; Provencher D; Pourreaux K; Kornegay J; Rouah F; Coutlée F;
    Clin Infect Dis; 2005 Aug; 41(4):527-34. PubMed ID: 16028163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Schuman P; Ohmit SE; Klein RS; Duerr A; Cu-Uvin S; Jamieson DJ; Anderson J; Shah KV;
    J Infect Dis; 2003 Jul; 188(1):128-36. PubMed ID: 12825181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High level of HPV 16 and 18 DNA load in anal swabs from male and female HIV-1 infected patients.
    Poizot-Martin I; Henry M; Benhaim S; Obry-Roguet V; Figarella D; Tamalet C
    J Clin Virol; 2009 Apr; 44(4):314-7. PubMed ID: 19269245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.
    Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
    J Infect Dis; 2013 Jun; 207(11):1723-9. PubMed ID: 23463709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.
    Lillo FB; Ferrari D; Veglia F; Origoni M; Grasso MA; Lodini S; Mastrorilli E; Taccagni G; Lazzarin A; Uberti-Foppa C
    J Infect Dis; 2001 Sep; 184(5):547-51. PubMed ID: 11494160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples.
    Mbulawa ZZ; Marais DJ; Johnson LF; Boulle A; Coetzee D; Williamson AL
    J Gen Virol; 2010 Dec; 91(Pt 12):3023-31. PubMed ID: 20719990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.